Related Experiment Video
Updated: Sep 20, 2025
06:41
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
12.6K
Extracorporeal Membrane Oxygenation in COVID-19
Manuel Tisminetzky1, Bruno L Ferreyro2, Eddy Fan3
1Department of Medicine, Division of Respirology, Sinai Health System and University Health Network, 585 University Avenue, 9-MaRS-9013, Toronto, Ontario M5G2G2, Canada.
Critical Care Clinics
|June 6, 2022
Summary
Extracorporeal membrane oxygenation (ECMO) is a vital treatment for severe acute respiratory distress syndrome (ARDS). Evidence shows ECMO is as effective and safe for COVID-19 ARDS as for other forms, offering a chance to refine its use.
Area of Science:
- Critical Care Medicine
- Pulmonology
- Infectious Diseases
Background:
- Severe acute respiratory distress syndrome (ARDS) requires advanced respiratory support.
- COVID-19-associated ARDS shares similarities with ARDS from other causes.
- Established evidence-based practices are crucial for managing ARDS.
Purpose of the Study:
- To evaluate the efficacy and safety of ECMO in COVID-19 ARDS.
- To compare ECMO outcomes in COVID-19 ARDS versus non-COVID-19 ARDS.
- To identify opportunities for optimizing ECMO therapy in the context of the pandemic.
Main Methods:
- Review of current evidence on ECMO for ARDS.
- Comparison of clinical outcomes and safety profiles.
- Analysis of management strategies including lung-protective ventilation and prone positioning.
Main Results:
- ECMO demonstrates similar efficacy and safety in COVID-19 ARDS as in non-COVID-19 ARDS.
- Standard ARDS management principles, including ECMO, are applicable to COVID-19.
- The increased use of ECMO during the pandemic provides valuable data for optimization.
Conclusions:
- ECMO is a viable and comparable treatment option for severe COVID-19 ARDS.
- Consistent application of evidence-based ARDS management is recommended.
- Further research is warranted to optimize ECMO protocols and improve patient outcomes.
Related Concept Videos
01:30Acute Respiratory Failure-III
341
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
341
01:21Acute Respiratory Failure-II
389
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
389
01:29Acute Respiratory Failure-V
217
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
217
01:23Acute Respiratory Failure-IV
243
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
243
01:21Acute Respiratory Failure-I
350
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
350
01:16Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
1.0K
Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
1.0K